Capmatinib (Tabrecta): A Patient Guide for MET-Mutant Lung Cancer
Capmatinib targets advanced lung cancer with MET exon 14 skipping.
KESHAV
現在販売中の商品に関連する医薬品情報、適応症、用法用量、安全上の注意を掲載しています。
Capmatinib targets advanced lung cancer with MET exon 14 skipping.
This is a landmark decision that will improve treatment options for children who have low and hi…
Oral tumors are relatively common in dogs, and canine oral squamous cell carcinoma (COSCC) is th…
Combination therapy with dabrafenib and trametinib has been shown to improve response and surviv…